J7524: Mycophenolate mofetil, oral, 5 mg
J7524 is a HCPCS Level II code for mycophenolate mofetil, oral, 5 mg. It belongs to the Drugs Administered Other Than Oral Method section. Whether Medicare pays it depends on the coverage rule below.
Medicare coverage: Carrier judgment
Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q4-Oct. This states Medicare’s position on the code, not on your particular claim.
The CMS record for J7524
- Long descriptor
- Mycophenolate mofetil, oral, 5 mg
- Short descriptor
- Mycophenol mofetil oral 5 mg
- Added
- October 1, 2026
- BETOS
- O1E
- Pricing indicator
- 51: Other
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
Berenson-Eggers Type of Service: CMS's own analytic grouping.
Drugs.
Codes adjacent to J7524
HCPCS has no hierarchy: related items simply sit next to each other in the numbering. If J7524 is not quite right, the correct code is very often within a few positions of it.
- J7514Mycophenolate mofetil (myhibbin), oral suspension, 100 mgterminated
- J7515Cyclosporine, oral, 25 mg
- J7516Injection, cyclosporine, 250 mg
- J7517Mycophenolate mofetil, oral, 250 mgterminated
- J7518Mycophenolic acid, oral, 180 mg
- J7519Injection, mycophenolate mofetil, 10 mgterminated
- J7520Sirolimus, oral, 1 mg
- J7521Tacrolimus, granules, oral suspension, 0.1 mg
- J7525Tacrolimus, parenteral, 5 mg
- J7526Injection, mycophenolate mofetil, 5 mg
- J7527Everolimus, oral, 0.25 mg
- J7528Mycophenolate mofetil, for suspension, oral, 100 mgterminated
- J7529Mycophenolate mofetil, for suspension, oral, 5 mg
- J7530Mycophenolate mofetil (myhibbin), oral suspension, 5 mg
- J7531Prednisolone sodium phosphate, orally disintegrating tablet, 1 mg
- J7599Immunosuppressive drug, not otherwise classified